US Tariff Threat May Hit Indian Pharma Earnings by Up to 10%: SBI Research Warns
SBI Research warns that a planned 50% tax on Indian pharmaceutical exports could cut profits and hurt India's important role in the global supply...
US State Dept. Calls India ‘Strategic Partner’ While Standing Firm on Tariffs
Despite a full-blown tariff dispute and a direct halt to trade talks from President Trump, a top State Department official insists the US is...
